Collegium Pharmaceutical Correlations

COLL Stock

USD 30.71 0.48 1.54%

The current 90-days correlation between Collegium Pharmaceutical and Phibro Animal Health is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Collegium Pharmaceutical Correlation With Market

Weak diversification

The correlation between Collegium Pharmaceutical and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.

Moving together with Collegium Stock

0.64	VALN	Valneva SE ADR	Pair Corr
0.78	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.86	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.86	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.66	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.61	BIAFW	BioAffinity Technologies	Pair Corr
0.69	MREO	Mereo BioPharma Group	Pair Corr
0.71	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.77	PDSB	PDS Biotechnology Corp	Pair Corr
0.94	PEPG	PepGen	Pair Corr
0.65	ABBV	AbbVie Inc	Pair Corr
0.68	ADAP	Adaptimmune Therapeutics	Pair Corr
0.78	AMGN	Amgen Inc	Pair Corr
0.66	ANEB	Anebulo Pharmaceuticals	Pair Corr

Moving against Collegium Stock

0.76	NAMS	NewAmsterdam Pharma	Pair Corr
0.75	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.64	GILD	Gilead Sciences	Pair Corr
0.64	PMVP	Pmv Pharmaceuticals	Pair Corr
0.52	PHVS	Pharvaris BV	Pair Corr
0.37	ESLAW	Estrella Immunopharma	Pair Corr
0.35	LPCN	Lipocine	Pair Corr
0.35	PLRX	Pliant Therapeutics	Pair Corr
0.32	LPTX	Leap Therapeutics	Pair Corr
0.84	VREX	Varex Imaging Corp	Pair Corr
0.82	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.81	AGIO	Agios Pharm	Pair Corr
0.8	AVTE	Aerovate Therapeutics	Pair Corr
0.76	CDXS	Codexis	Pair Corr
0.75	CRVS	Corvus Pharmaceuticals	Pair Corr
0.39	CMND	Clearmind Medicine Common	Pair Corr
0.31	ANTX	AN2 Therapeutics	Pair Corr

Related Correlations Analysis

	PAHC	PROC	AMPH	ALKS	EOLS	PBH	PCRX	ITCI
PAHC		-0.51	0.18	0.29	-0.35	0.46	0.73	0.65	PAHC
PROC	-0.51		0.45	-0.23	0.86	-0.88	-0.39	-0.68	PROC
AMPH	0.18	0.45		-0.08	0.64	-0.37	0.25	0.0	AMPH
ALKS	0.29	-0.23	-0.08		-0.29	0.36	0.31	0.29	ALKS
EOLS	-0.35	0.86	0.64	-0.29		-0.88	-0.29	-0.6	EOLS
PBH	0.46	-0.88	-0.37	0.36	-0.88		0.41	0.78	PBH
PCRX	0.73	-0.39	0.25	0.31	-0.29	0.41		0.6	PCRX
ITCI	0.65	-0.68	0.0	0.29	-0.6	0.78	0.6		ITCI
	PAHC	PROC	AMPH	ALKS	EOLS	PBH	PCRX	ITCI

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

EOLS	+ 0.86	PROC
ITCI	+ 0.78	PBH
PCRX	+ 0.73	PAHC
ITCI	+ 0.65	PAHC
EOLS	+ 0.64	AMPH
ITCI	+ 0.6	PCRX

High negative correlations

PBH	- 0.88	EOLS
PBH	- 0.88	PROC
ITCI	- 0.68	PROC
ITCI	- 0.6	EOLS
PROC	- 0.51	PAHC
PCRX	- 0.39	PROC

Risk-Adjusted Indicators

There is a big difference between Collegium Stock performing well and Collegium Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Collegium Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PAHC	1.82	0.02	0.04	0.13	1.72	(2.08)	3.86	(2.45)	9.05
PROC	6.78	(0.16)	0.02	0.07	8.01	(11.46)	10.56	(13.11)	111.85
AMPH	1.60	(0.25)	0.00	(0.09)	0.00	0.00	3.37	(3.61)	17.30
ALKS	1.76	(0.16)	(0.03)	0.03	2.06	(1.94)	4.14	(3.59)	9.74
EOLS	2.44	(0.38)	0.00	(0.29)	0.00	0.00	4.49	(4.70)	22.78
PBH	0.94	0.12	0.07	0.29	1.04	(1.01)	1.90	(1.76)	4.90
PCRX	1.92	0.11	0.05	0.22	2.09	(2.11)	3.96	(3.67)	10.38
ITCI	1.35	0.14	0.07	0.30	1.33	(1.63)	3.04	(2.53)	16.17

Collegium Pharmaceutical Corporate Management

Shirley JD	General VP	Profile
Bart Dunn	Executive Development	Profile
Scott Sudduth	Head Operations	Profile
Christopher MD	Vice Relations	Profile
Marlo Manning	Head HR	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC